Ziarco Pharma's Series B Round

Ziarco Pharma raised a round of funding on November 10, 2014.

Ziarco is a dermatology therapeutics firm that develops a range of oral and topical products for the treatment of atopic dermatitis and psoriasis. Ziarco's lead candidate, ZPL-389, is a once-daily ora…

Articles about Ziarco Pharma's Series B Round: